A controlled trial found that methamphetamine attenuated several low-dose alcohol effects on laboratory cognition and sustained subjective stimulation. It did not establish that the combination is safe, that alcohol had been eliminated, or that participants could drive normally.
Hayley and colleagues studied 16 healthy adults across four experimental sessions: placebo, oral methamphetamine, alcohol, and their combination. Methamphetamine was administered at 0.42 mg/kg. The alcohol dose targeted approximately 0.04% BAC, but observed peak breath-derived BAC estimates were lower: 0.029% with alcohol and 0.030% with the combination.
This distinction between target and observed exposure matters. The experiment cannot be described as demonstrating effects at every higher alcohol concentration. Its neurocognitive tasks measured reaction time, vigilance and working memory, alongside subjective stimulation, sedation and cardiovascular measures.
Alcohol alone impaired performance across multiple tested functional domains relative to placebo and methamphetamine alone. Methamphetamine attenuated these effects in the combination condition. Methamphetamine alone produced an isolated psychomotor-speed improvement. These findings do not mean that every cognitive measure improved or that all adverse effects disappeared.
Subjective stimulation remained prominent with the combination. Methamphetamine-related cardiovascular elevations also occurred. Feeling less sedated cannot be substituted for a complete assessment of physiological or behavioral risk.
Methamphetamine concentrations were measured in oral fluid, while the BAC estimates came from breath testing. At the measured times, oral-fluid methamphetamine did not differ significantly between methamphetamine alone and the combination; breath-derived alcohol estimates likewise did not differ significantly between the alcohol conditions. These are specimen- and time-specific comparisons, not direct blood methamphetamine measurements.
The analytical observations do not show that methamphetamine removes alcohol from the body. Attenuation of a measured performance effect and accelerated elimination are different claims, requiring different evidence.
This was randomized controlled human primary research with a small selected sample and acute oral dosing. It did not test repeated consumption, severe intoxication, unrestricted street products or actual collision risk. Its results cannot establish an individual’s impairment from an oral-fluid number alone.
A case review should retain the actual exposure history, timing, observed behavior and specimen-specific findings. The study supports a warning about relying on how stimulated someone feels, not a recommendation to combine substances or a dosing strategy.
Our controlled driving-study discussion explains why isolated laboratory outcomes cannot be converted into a global declaration of driving safety.
Read the original investigation: doi:10.1177/02698811231179805.